ONCOPEPTIDES

Oncopeptides is a clinical stage company backed by HealthCap and Industrifonden that has raised approximately 16.5 MEUR in Early Stage and Series A financing to 2015. Oncopeptides lead compound, named melflufen, is a peptidase potentiated therapy within oncology. Melflufen is a very potent anti-angiogenetic compound, triggers rapid, robust, and irreversible DNA damage and exerts it cytotoxicity through alkylation of DNA. Melflufen is currently undergoing Phase 2 efficacy studies in patients with relapsed and relapsed-refractory multiple myeloma. The peptidase targeting causes melflufen and its metabolites to accumulate in the diseased cells. This results in targeted delivery of the active moieties to the cancer cells, and thereby better treatment of the disease.

#SimilarOrganizations #People #Financial #Event #Website #More

ONCOPEPTIDES

Industry:

Biotechnology Clinical Trials Pharmaceutical

Founded:

2000-01-01

Address:

Stockholm, Stockholms Lan, Sweden

Country:

Sweden

Website Url:

http://www.oncopeptides.com

Total Employee:

251+

Status:

Active

Contact:

46 7 05 69 54 71

Email Addresses:

[email protected]

Total Funding:

209.18 M USD

Technology used in webpage:

Domain Not Resolving Global Site Tag IPv6 US Privacy User Signal Mechanism DoubleClick.Net Cloudflare SSL Amazon Virginia Region Cloudflare CDN ASP.NET 4.0 ASP.NET Ajax

Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

Current Advisors List

jonas-brambeck_image

Jonas Brambeck Member of the Board of Directors @ Oncopeptides
Board_member

brian-stuglik_image

Brian Stuglik Board of Directors, Member @ Oncopeptides
Board_member
2018-01-01

johan-christenson_image

Johan Christenson Board member @ Oncopeptides
Board_member

per-samuelsson_image

Per Samuelsson Board member @ Oncopeptides
Board_member

Current Employees Featured

not_available_image

Rolf Larsson
Rolf Larsson Founder @ Oncopeptides
Founder
2000-01-01

joachim-gullbo_image

Joachim Gullbo
Joachim Gullbo Founder @ Oncopeptides
Founder
2000-01-01

diego-grauman_image

Diego Grauman
Diego Grauman Executive Director - USMA @ Oncopeptides
Executive Director - USMA
2021-03-01

not_available_image

Jakob Lindberg
Jakob Lindberg Chief Scientific Officer, CSO @ Oncopeptides
Chief Scientific Officer, CSO
2020-06-30

not_available_image

Annika Muskantor
Annika Muskantor CFO @ Oncopeptides
CFO

not_available_image

Peter Nygren
Peter Nygren Founder @ Oncopeptides
Founder
2000-01-01

anders-martin_image

Anders Martin
Anders Martin CFO & Deputy CEO @ Oncopeptides
CFO & Deputy CEO

Founder

joachim-gullbo_image

Joachim Gullbo

not_available_image

Peter Nygren

not_available_image

Rolf Larsson

Stock Details

Company's stock symbol is STO:ONCO

Investors List

vinnova_image

Key Employee Changes

Date	New article
2021-11-01	Oncopeptides appoints Annika Muskantor as interim CFO

Official Site Inspections

http://www.oncopeptides.com Semrush global rank: 437.71 K Semrush visits lastest month: 121.55 K

Host Informations
Whois Informations

Unable to get host informations!!!

Loading ...